Qrons Company
Qrons is a publicly-traded, preclinical biotechnology company that develops advanced cell-based solutions to combat neurological injuries.
Technology:
Bioengineering, Stem cell therapy
Industry:
BioEngineering, Public
Headquarters:
New York, New York, United States
Founded Date:
2016-01-01
Employees Number:
1-10
Funding Status:
IPO
Total Funding:
500000
Estimated Revenue:
Less than $1M
Last Funding Date:
2018-02-12
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership